TWI292314B - - Google Patents

Download PDF

Info

Publication number
TWI292314B
TWI292314B TW90102849A TW90102849A TWI292314B TW I292314 B TWI292314 B TW I292314B TW 90102849 A TW90102849 A TW 90102849A TW 90102849 A TW90102849 A TW 90102849A TW I292314 B TWI292314 B TW I292314B
Authority
TW
Taiwan
Prior art keywords
fluorophenyl
parkinson
physiologically acceptable
pharmaceutical composition
acceptable salt
Prior art date
Application number
TW90102849A
Other languages
English (en)
Chinese (zh)
Inventor
Bartoszyk Gerd
Russ Hermann
Seyfried Christoph
Weber Frank
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to TW90102849A priority Critical patent/TWI292314B/zh
Application granted granted Critical
Publication of TWI292314B publication Critical patent/TWI292314B/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW90102849A 2001-02-09 2001-02-09 TWI292314B (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW90102849A TWI292314B (pt) 2001-02-09 2001-02-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW90102849A TWI292314B (pt) 2001-02-09 2001-02-09

Publications (1)

Publication Number Publication Date
TWI292314B true TWI292314B (pt) 2008-01-11

Family

ID=45067490

Family Applications (1)

Application Number Title Priority Date Filing Date
TW90102849A TWI292314B (pt) 2001-02-09 2001-02-09

Country Status (1)

Country Link
TW (1) TWI292314B (pt)

Similar Documents

Publication Publication Date Title
CN102274517B (zh) 治疗帕金森病的方法
AU685510B2 (en) Potentiation of drug response
US6232326B1 (en) Treatment for schizophrenia and other dopamine system dysfunctions
AU2003284005B2 (en) Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
US20090137565A1 (en) Method for treatment of movement disorders
CN111278440A (zh) 用普利多匹定治疗肌萎缩性脊髓侧索硬化症的方法
EP1696905B1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
US4438119A (en) Method for alleviation of extrapyramidal motor disorders
JP6137833B2 (ja) 脱髄性および他の神経系疾患を患っている患者における神経認知的および／または神経精神医学的障害を改善するための４−アミノピリジンの使用
TW201841637A (zh) 使用ccr3-抑制劑治療老化相關損傷之方法及組合物
DE69607904T2 (de) Potenzierung von Serotonin-Wirkstoffresponz
WO2021030607A1 (en) Pimavanserin for treating neurodegenerative diseases
KR100830139B1 (ko) (ｒ)-(-)-2-[５-(４-플루오로페닐)-３-피리딜메틸아미노메틸]-크로만 및 이의 생리학적으로 허용가능한 염의 신규한 용도
EP2029139A1 (en) Use of a p38 kinase inhibitor for treating psychiatric disorders
JPH04327532A (ja) 活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤
ES2280602T3 (es) Uso de 2-(5-(4-fluorofenil)-3-piridilmetilaminometil)-cromano y sus sales fisiologicamente aceptables.
TWI292314B (pt)
JP2022031814A (ja) 不安障害を治療するための（２Ｓ）－１－［４－（３，４－ジクロロフェニル）ピペリジン－１－イル］－３－［２－（５－メチル－１，３，４－オキサジアゾール－２－イル）ベンゾ［ｂ］フラン－４－イルオキシ］プロパン－２－オールまたはその代謝産物
RU2320336C2 (ru) Новое применение замещенных аминометилхроманов для лечения нарушений движений или нежелательных действий, вызываемых средствами, которые вводятся для лечения экстрапирамидных нарушений движений
JP2942626B2 (ja) 神経学的疾患を治療するための４，４′―〔９ｈ―フルオレン―９―イリデンビス（メチレン）〕ビスピリミジン
EP0818198A1 (en) Potentiation of drug response by increasing serotonin availability
Zare et al. Wake-Promoting agents; insights into clinical use and molecular perspectives
WO2024102802A1 (en) Zelatriazin for the treatment of depression
Maan Comparison of Methamphetamine and MDMA Extended Access Self-administration: Acquisition, Maintenance, and Response Patterns
JPS6241208B2 (pt)

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees